Categories AlphaGraphs, Earnings, Health Care
Dentsply Sirona (XRAY) slips to a loss in Q1 but beats estimates
Dentsply Sirona Inc. (NASDAQ: XRAY) reported its preliminary financial results for the quarter ended March 31, 2020, on Friday before the bell. The results exceeded analysts’ expectations.
Dentsply Sirona slipped to a loss in the first quarter of 2020 from a profit last year, due to an Equipment & Instruments non-cash goodwill impairment and an intangible impairment. The Equipment & Instruments unit showed weakness in sales due to the ongoing COVID-19 impact on customer demand.
![Dentsply Sirona (XRAY) Q1 2020 earnings review](https://cdn.news.alphastreet.com/wp-content/uploads/2020/05/Dentsply-Sirona-Q1-2020-Earnings-Infographic.jpg)
The dentists and customers reduced dental visits and procedures in response to the coronavirus pandemic. As a result of the uncertainty around the duration of the COVID-19 pandemic and its impact on the business, the company previously withdrew its 2020 guidance.
During the first quarter, the company bought back shares for a total cost of $140 million. In addition, the company paid $22.1 million in dividends resulting in a total of $162.1 million returned to shareholders during the first quarter of 2020.
Take a look at the rest of our Healthcare articles here
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%